Humacyte Inc.

$HUMA is down today and the biggest laggard in the Prism MarketView MedDevices index after they priced a $50 million public offering of 25 million common shares at $2.00 per share.

Share this article:

About the Author:

Humacyte Inc.

Joey Ramson

PRISM Market View Alerts

Get your dose of PRISM Market
View news, right in your inbox

Mailchimp Signup